STAQ Pharma recalls
FDA enforcement reports naming STAQ Pharma, Inc. as the recalling firm.
- Recall reports
- 6
- Class I (serious)
- 2
- Most recent report
- Oct 22, 2025
- Oct 22, 2025Hydromorphone HCL PF, 10mg/50 mL (0Drug · STAQ Pharma, Inc.Labeling: Incorrect or Missing Lot and/or Exp DateClass III
- Oct 22, 2025Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ…Drug · STAQ Pharma, Inc.Labeling: Incorrect or Missing Lot and/or Exp DateClass III
- Oct 22, 2025FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syrin…Drug · STAQ Pharma, Inc.Labeling: Incorrect or Missing Lot and/or Exp DateClass III
- Dec 13, 2023ROPivacaine HCl 0Drug · STAQ Pharma, Inc.STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 13…Class II
- Feb 23, 2022HYDROmorphone HCl PF 10 mg/50 mL (0Drug · STAQ Pharma, Inc.Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221AClass I
- Feb 23, 2022Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, R…Drug · STAQ Pharma, Inc.Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221AClass I